362 related articles for article (PubMed ID: 27209063)
21. The efficacies of artesunate-sulfadoxine-pyrimethamine and artemether-lumefantrine in the treatment of uncomplicated, Plasmodium falciparum malaria, in an area of low transmission in central Sudan.
Mohamed AO; Eltaib EH; Ahmed OA; Elamin SB; Malik EM
Ann Trop Med Parasitol; 2006 Jan; 100(1):5-10. PubMed ID: 16417707
[TBL] [Abstract][Full Text] [Related]
22. Five years of large-scale dhfr and dhps mutation surveillance following the phased implementation of artesunate plus sulfadoxine-pyrimethamine in Maputo Province, Southern Mozambique.
Raman J; Little F; Roper C; Kleinschmidt I; Cassam Y; Maharaj R; Barnes KI
Am J Trop Med Hyg; 2010 May; 82(5):788-94. PubMed ID: 20439956
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zérékoré.
Bonnet M; Roper C; Félix M; Coulibaly L; Kankolongo GM; Guthmann JP
Malar J; 2007 May; 6():54. PubMed ID: 17477865
[TBL] [Abstract][Full Text] [Related]
24. Surveillance of molecular markers for antimalarial resistance in Zambia: Polymorphism of Pfkelch 13, Pfmdr1 and Pfdhfr/Pfdhps genes.
Sitali L; Mwenda MC; Miller JM; Bridges DJ; Hawela MB; Hamainza B; Mudenda-Chilufya M; Chizema-Kawesha E; Daniels RF; Eisele TP; Nerland AH; Chipeta J; Lindtjorn B
Acta Trop; 2020 Dec; 212():105704. PubMed ID: 33002448
[TBL] [Abstract][Full Text] [Related]
25. Molecular monitoring of resistant dhfr and dhps allelic haplotypes in Morogoro and Mvomero districts in south eastern Tanzania.
Malisa A; Pearce R; Abdullah S; Mutayoba B; Mshinda H; Kachur P; Bloland P; Roper C
Afr Health Sci; 2011 Jun; 11(2):142-50. PubMed ID: 21857842
[TBL] [Abstract][Full Text] [Related]
26. Different methodological approaches to the assessment of in vivo efficacy of three artemisinin-based combination antimalarial treatments for the treatment of uncomplicated falciparum malaria in African children.
Ashley EA; Pinoges L; Turyakira E; Dorsey G; Checchi F; Bukirwa H; van den Broek I; Zongo I; Urruta PP; van Herp M; Balkan S; Taylor WR; Olliaro P; Guthmann JP
Malar J; 2008 Aug; 7():154. PubMed ID: 18691429
[TBL] [Abstract][Full Text] [Related]
27. Artemisinin-based combination therapy for treating uncomplicated malaria.
Sinclair D; Zani B; Donegan S; Olliaro P; Garner P
Cochrane Database Syst Rev; 2009 Jul; 2009(3):CD007483. PubMed ID: 19588433
[TBL] [Abstract][Full Text] [Related]
28. High efficacy of two artemisinin-based combinations: artesunate + sulfadoxine-pyrimethamine and artemether-lumefantrine for falciparum malaria in Yemen.
Adeel AA; Saeed NA; Aljasari A; Almohager AM; Galab MH; AlMahdi A; Mahammed MH; AlDarsi M; Salaeah YA; Atta H; Zamani G; Warsame M; Barrette A; Mohammady HE; Nada RA
Malar J; 2015 Nov; 14():449. PubMed ID: 26573814
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of a fixed dose artesunate-sulphamethoxypyrazine-pyrimethamine compared to artemether-lumefantrine for the treatment of uncomplicated falciparum malaria across Africa: a randomized multi-centre trial.
Sagara I; Rulisa S; Mbacham W; Adam I; Sissoko K; Maiga H; Traore OB; Dara N; Dicko YT; Dicko A; Djimdé A; Jansen FH; Doumbo OK
Malar J; 2009 Apr; 8():63. PubMed ID: 19366448
[TBL] [Abstract][Full Text] [Related]
30. High prevalence of quintuple mutant dhps/dhfr genes in Plasmodium falciparum infections seven years after introduction of sulfadoxine and pyrimethamine as first line treatment in Malawi.
Bwijo B; Kaneko A; Takechi M; Zungu IL; Moriyama Y; Lum JK; Tsukahara T; Mita T; Takahashi N; Bergqvist Y; Björkman A; Kobayakawa T
Acta Trop; 2003 Mar; 85(3):363-73. PubMed ID: 12659974
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of sulfadoxine-pyrimethamine resistance-associated mutations in dhfr and dhps genes of Plasmodium falciparum three years after SP withdrawal in Bahir Dar, Northwest Ethiopia.
Hailemeskel E; Kassa M; Taddesse G; Mohammed H; Woyessa A; Tasew G; Sleshi M; Kebede A; Petros B
Acta Trop; 2013 Dec; 128(3):636-41. PubMed ID: 24055717
[TBL] [Abstract][Full Text] [Related]
32. Comparison of artemether-lumefantrine with sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in eastern Nepal.
Thapa S; Hollander J; Linehan M; Cox-Singh J; Bista MB; Thakur GD; Davis WA; Davis TM
Am J Trop Med Hyg; 2007 Sep; 77(3):423-30. PubMed ID: 17827354
[TBL] [Abstract][Full Text] [Related]
33. dhfr and dhps genotype and sulfadoxine-pyrimethamine treatment failure in children with falciparum malaria in the Democratic Republic of Congo.
Alker AP; Kazadi WM; Kutelemeni AK; Bloland PB; Tshefu AK; Meshnick SR
Trop Med Int Health; 2008 Nov; 13(11):1384-91. PubMed ID: 19055622
[TBL] [Abstract][Full Text] [Related]
34. A trial of combination antimalarial therapies in children from Papua New Guinea.
Karunajeewa HA; Mueller I; Senn M; Lin E; Law I; Gomorrai PS; Oa O; Griffin S; Kotab K; Suano P; Tarongka N; Ura A; Lautu D; Page-Sharp M; Wong R; Salman S; Siba P; Ilett KF; Davis TM
N Engl J Med; 2008 Dec; 359(24):2545-57. PubMed ID: 19064624
[TBL] [Abstract][Full Text] [Related]
35. High prevalence of pfdhfr-pfdhps triple mutations associated with anti-malarial drugs resistance in Plasmodium falciparum isolates seven years after the adoption of sulfadoxine-pyrimethamine in combination with artesunate as first-line treatment in Iran.
Rouhani M; Zakeri S; Pirahmadi S; Raeisi A; Djadid ND
Infect Genet Evol; 2015 Apr; 31():183-9. PubMed ID: 25653131
[TBL] [Abstract][Full Text] [Related]
36. Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania.
Mbugi EV; Mutayoba BM; Malisa AL; Balthazary ST; Nyambo TB; Mshinda H
Malar J; 2006 Oct; 5():94. PubMed ID: 17076899
[TBL] [Abstract][Full Text] [Related]
37. Artemether-Lumefantrin (Coartem) and artesunate with sulfadoxine-pyrimethamine therapeutic efficacy in the treatment of uncomplicated malaria at Gilgel Gibe II (GGII) South-Western Ethiopia.
Seboxa T; Mao P; Pinchouk N; Anbessie J; Alemu H; Diro E
Ethiop Med J; 2010 Oct; 48(4):285-91. PubMed ID: 21280430
[TBL] [Abstract][Full Text] [Related]
38. Declining efficacy of artesunate plus sulphadoxine-pyrimethamine in northeastern India.
Mishra N; Kaitholia K; Srivastava B; Shah NK; Narayan JP; Dev V; Phookan S; Anvikar AR; Rana R; Bharti RS; Sonal GS; Dhariwal AC; Valecha N
Malar J; 2014 Jul; 13():284. PubMed ID: 25052385
[TBL] [Abstract][Full Text] [Related]
39. Prevailing Plasmodium falciparum dihydrofolate reductase 108-asparagine in Hodeidah, Yemen: a questionable sulfadoxine-pyrimethamine partner within the artemisinin-based combination therapy.
Abdul-Ghani R; Farag HF; Allam AF; Shawky SM
Acta Trop; 2014 Apr; 132():39-44. PubMed ID: 24406851
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India.
Valecha N; Srivastava P; Mohanty SS; Mittra P; Sharma SK; Tyagi PK; Pradhan K; Dev V; Singh R; Dash AP; Sharma YD
Malar J; 2009 May; 8():107. PubMed ID: 19454000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
